Zelira Therapeutics (AU:ZLD) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Zelira Therapeutics Limited has announced the issuance of 3.5 million unquoted convertible notes as part of previously disclosed transactions. These securities are not intended to be quoted on the Australian Securities Exchange. Investors may find this development indicative of the company’s strategic financial maneuvers.
For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue